Pfizer Inc (PFE.N) on Thursday said it has stopped a late-stage study of its drug Sutent among patients with advanced breast cancer due to apparent lack of effectiveness, but is continuing with other studies among the ...
Sourse: More Info
Thursday, April 2, 2009
Pfizer's Sutent fails breast cancer study
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment